Home › Medicines › Optipeg-A
বাংলায় দেখুন
💊

Optipeg-A

SC Injection

🧬 Peginterferon alfa-2a [Pegylated Interferon alfa-2a] 🏢 Incepta Pharmaceuticals Ltd.
Generic Name Peginterferon alfa-2a [Pegylated Interferon alfa-2a]
Manufacturer Incepta Pharmaceuticals Ltd.
Unit Price 0.5 ml pre-filled syringe: ৳ 8,800.00

🔹 Indications

Chronic Hepatitis C: Optipeg-A, alone or in combination with Ribavirin, is indicated for the treatment of aadults with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not been previously treated with interferon alpha.

Chronic Hepatitis B: Optipeg-A, is indicated for the treatment of adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation.

🔹 Pharmacology

Chronic Hepatitis C: Optipeg-A, alone or in combination with Ribavirin, is indicated for the treatment of aadults with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not been previously treated with interferon alpha.

Chronic Hepatitis B: Optipeg-A, is indicated for the treatment of adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation.

🔹 Dosage & Administration

Chronic Hepatitis C: Optipeg-A, alone or in combination with Ribavirin, is indicated for the treatment of aadults with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not been previously treated with interferon alpha.

Chronic Hepatitis B: Optipeg-A, is indicated for the treatment of adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation.

🔹 Interaction

Chronic Hepatitis C: Optipeg-A, alone or in combination with Ribavirin, is indicated for the treatment of aadults with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not been previously treated with interferon alpha.

Chronic Hepatitis B: Optipeg-A, is indicated for the treatment of adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation.

🔹 Contraindications

Chronic Hepatitis C: Optipeg-A, alone or in combination with Ribavirin, is indicated for the treatment of aadults with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not been previously treated with interferon alpha.

Chronic Hepatitis B: Optipeg-A, is indicated for the treatment of adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation.

🔹 Side Effects

Chronic Hepatitis C: Optipeg-A, alone or in combination with Ribavirin, is indicated for the treatment of aadults with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not been previously treated with interferon alpha.

Chronic Hepatitis B: Optipeg-A, is indicated for the treatment of adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation.

🔹 Pregnancy & Lactation

Chronic Hepatitis C: Optipeg-A, alone or in combination with Ribavirin, is indicated for the treatment of aadults with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not been previously treated with interferon alpha.

Chronic Hepatitis B: Optipeg-A, is indicated for the treatment of adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation.

🔹 Precautions & Warnings

Chronic Hepatitis C: Optipeg-A, alone or in combination with Ribavirin, is indicated for the treatment of aadults with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not been previously treated with interferon alpha.

Chronic Hepatitis B: Optipeg-A, is indicated for the treatment of adult patients with HBeAg positive and HBeAg negative chronic hepatitis B infection who have compensated liver disease and evidence of viral replication and liver inflammation.

🔍 People also search for

Optipeg-A Optipeg-A SC Injection used for Optipeg-A side effects Optipeg-A price Optipeg-A dose Optipeg-A SC Injection uses Is Optipeg-A safe Optipeg-A dosage Optipeg-A alternative Optipeg-A Bangladesh Peginterferon alfa-2a [Pegylated Interferon alfa-2a] Peginterferon alfa-2a [Pegylated Interferon alfa-2a] price Bangladesh SC Injection price Bangladesh Incepta Pharmaceuticals Ltd. medicine bd

💡 Frequently Asked Questions

Chronic Hepatitis C: Optipeg-A, alone or in combination with Ribavirin, is indicated for the treatment of aadults with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not been previously treated with interferon a...
Chronic Hepatitis C: Optipeg-A, alone or in combination with Ribavirin, is indicated for the treatment of aadults with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not been previously treated with interferon a...
Chronic Hepatitis C: Optipeg-A, alone or in combination with Ribavirin, is indicated for the treatment of aadults with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not been previously treated with interferon a...

User Reviews

⭐
No reviews yet!
Be the first to share your experience.

Write a Review

Alternative Medicines
(Same Generic)

Optipeg-A SC Injection

Incepta Pharmaceuticals Ltd.

0.5 ml pre-filled syringe: ৳ 9,800.00

Pegin SC Injection

Beacon Pharmaceuticals PLC

0.5 ml pre-filled syringe: ৳ 9,800.00